Assistant Professor, Medicine - (Clinical Scholar Track)
I am an Assistant Professor, at the Division of Pulmonary and Critical Care Medicine at the University of Arizona Health Sciences Center. My research interests include understanding mechanisms, genetics and pathogenisis of patients with Idiopathic Pulmonary Fibrosis and other forms of Interstitial Lung diseases. I have various ongoing clinical trials and also I cuurenty have an investigator initiated grant looking at the effects of sleep apnea and GERD in the progression and exacerbation of idiopathic pulmonary fibrosis. My future research interest includes looking at the role of antifibrotics in post lung transplant rejection.
Since the completion of my fellowship training in Pulmonary and Critical Care, my clinical focus has been Interstitial Lung Diseases (ILD). Currently, I am the Director of the ILD clinic at the University of Arizona Medical Center. We are proud to be part of the Pulmonary Fibrosis Foundation which has opened several avenues of clinical research. We are actively involved in Bio-banking and currently in the process of exome and genome sequencing studies involving Mucin receptors in various Interstitial Lung Diseases. I am the principal investigator on two clinical trials, which are to evaluate the safety, tolerability, and activity of KD025 in subjects with IPF and efficacy and safety of Nintedanib in progressive ILD. We have available local clinical expertise and basic science support to further the field of Interstitial Lung Disease, with a particular focus in Idiopathic Pulmonary Fibrosis (IPF) and acute exacerbations of IPF.